Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Pfizer’s Ibrance combo authorised via the Cancer Drugs Fund for advanced breast cancer

January 15, 2020 Research and Development Cancer Drugs Fund, NICE, Pfizer, ibrance, pharma

NICE, the drug watchdog for England and Wales, has given its approval for Pfizer’s Ibrance (palbociclib) in combination with AstraZeneca’s …
News
131224-f-im476-001

Rochester Drug Cooperative ceases opioid sales following criminal charges

January 15, 2020 Research and Development Bernie Sanders, Trump opioids, opioid, opioid crisis, opioids

The Rochester Drug Cooperative (RDC) has announced it will no longer distribute opioid medications after two of its executives were …
News
48721589102_164e25393b_b

Democrat Presidential Candidates pledge to lower drug prices without Congress’ help

January 15, 2020 Research and Development Bernie Sanders, GOP, Trump, US President, US Presidential Election, democrats, republican

Two Democratic presidential candidates said that if they are elected president they will act immediately to reduce the cost of …
News
jp-kress_mor

Working Life Interview: Jean-Paul Kress, CEO of MorphoSys

January 13, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Working Life, feature, morphosys, pharma

With a medical doctorate as well as degrees in pharmacology and immunology under your belt, was your path always to …
Feature
4420456374_64a3d7e6aa_88

Top Ten most popular articles on Pharmafile.com this week

January 10, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The US pharamaceutical industry dominates the news this week, with Pfizer, Sanofi and GlaxoSmithKline all increasing their drug prices while …
News
novartis_window

Novartis’ ligelizumab tops Xolair in chronic spontaneous urticaria

January 9, 2020 Research and Development Novartis, Xolair, ligelizumab

Novartis has provided a burst of new data directly comparing its therapy ligelizumab with the current standard of care Xolair …
News
nmpa_logo

China approves first homegrown HPV vaccine

January 8, 2020 Research and Development, Sales and Marketing China, HPV, NMPA, pharma, vaccines

Female patients in China between the ages of nine and 45 will have access to the country’s first domestically-produced vaccine …
News
26795071995_1a72be4ca3_b

No link between talc and ovarian cancer, new study reveals

January 8, 2020 Research and Development . Johnson & Johnson, Johnson & Johnson, baby powder, talc, talc powder

Researchers examining data from over 252,000 women have concluded that there is no statistically significant link between the use of …
News
shutterstock

Apellis therapy outflanks Alexion’s Soliris in head-to-head paroxysmal nocturnal haemoglobinuria

January 8, 2020 Research and Development Alexion, Appelis, pegcetacoplan, pharma, soliris

Apellis Pharmaceuticals has revealed new Phase 3 demonstrating that its targeted C3 inhibitor pegcetacoplan met its primary endpoint and outclassed …
News
14281921538_bacbef11bc_b

Pharmacies argue that prescribers bear ultimate responsibility for the opioid crisis

January 8, 2020 Research and Development Bernie Sanders, OxyContin, opioid crisis, opioids

Pharmacy chains have argued in federal court that doctors and healthcare practitioners who write prescriptions bear ultimate responsibility for the …
News
abbottweb

FDA approves alternative approach for Abbot HeartMate 3 heart pump

January 8, 2020 Research and Development Abbott, FDA, Heart Pump, US Pharma, heart disease

The FDA announced today that it has approved a new alternative surgical technique for Abbot’s HeartMate 3 heart pump. The …
News
rami-levin-picture-3-002

Saniona appoints Rami Levin as President and Chief Executive Officer

January 8, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointments, rare diseases

Saniona has announced that Rami Levin will take over as the Chief Executive Officer of the company as it seeks …
Appointment
enrique_conterno

FibroGen names Lilly veteran as new CEO

January 7, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, fibrogen, pharma

Eli Lilly veteran Enrique Conterno has been revealed as the new Chief Executive Officer of FibroGen following the unexpected death …
Appointment
glenmark

FDA approves Glenmark’s generic version of Novartis’ Exjade tablets for chronic iron overload

January 7, 2020 Manufacturing and Production, Research and Development Glenmark, exjade, generic, pharma

Indian pharma firm Glenmark has announced it has secured approval from the FDA for its oral deferasirox tablets in the …
News
shutterstock_38078521

Bavencio extends survival at Phase 3 in previously untreated locally advanced or metastatic urothelial carcinoma

January 7, 2020 Manufacturing and Production, Research and Development Bavencio, Merck KGaA, Pfizer, pharma

Bavencio (avelumab), the anti-programmed death ligand-1 (PD-L1) antibody co-developed by Pfizer and Merck KGaA’s biopharma unit EMD Serono, has been …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025